Internal Medicine, Pulmonary Disease · Rochester, MN
NPI
1184694770
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
200 1st St SW
Rochester, MN, 55905
Phone (507) 284-2511
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
1,524 services
Medicare patients, 2024
674
Average age 73
Drug cost, 2024
$81K
642 prescriptions
Company payments, 2025
$0
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy R Aksamit was code 94729 (pulmonary function testing), 274 times for 274 patients. In total Timothy R Aksamit billed 1,524 services in 29 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94729 Pulmonary Function Testing | Office | 274 | 274 | $46.37 | $13K |
| 94726 Pulmonary Function Testing | Office | 196 | 196 | $46.32 | $9,078 |
| 94010 Pulmonary Function Testing | Office | 173 | 171 | $22.07 | $3,819 |
| 94762 Pulmonary | Office | 157 | 156 | $19.77 | $3,103 |
| 99233 Hospital E&M - Subsequent | Facility | 106 | 40 | $94.05 | $9,970 |
| 99215 Office E&M - Established | Office | 101 | 84 | $142.33 | $14K |
| 94060 Pulmonary Function Testing | Office | 97 | 97 | $32.06 | $3,110 |
| G0237 Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring) | Office | 80 | 26 | $9.03 | $722 |
| 94618 Pulmonary Function Testing | Office | 57 | 56 | $18.26 | $1,041 |
| 95012 Pulmonary | Office | 56 | 56 | $15.12 | $847 |
| 99205 Office E&M - New | Office | 46 | 46 | $175.15 | $8,057 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 42 | 42 | $26.10 | $1,096 |
| 94070 Pulmonary Function Testing | Office | 31 | 31 | $45.62 | $1,414 |
| J7674 Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg | Office | 25 | 25 | $0.92 | $23.11 |
| 95070 Test - Miscellaneous | Office | 25 | 25 | $28.16 | $704 |
By year: 2022 $94K for 1,965 services; 2023 $110K for 2,563 services; 2024 $73K for 1,524 services.
Medicare prescription drug claims, 2024
In 2024, the drug Timothy R Aksamit prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 68 prescriptions and refills. In total Timothy R Aksamit wrote 642 Medicare prescriptions that cost $81K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 68 | 74 | 30 | $2,295 |
| Famotidine Generic | 51 | 118 | 18 | $639 |
| Ethambutol Hcl Generic | 46 | 62 | Under 11 | $1,600 |
| Colistimethate Colistin (Colistimethate Na) | 38 | 42 | Under 11 | $19K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 37 | 37 | 20 | $615 |
| Azithromycin Generic | 37 | 57 | Under 11 | $533 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 32 | 42 | Under 11 | $3,990 |
| Ipratropium Bromide Generic | 27 | 39 | Under 11 | $729 |
| Rifampin Generic | 26 | 36 | Under 11 | $794 |
| Levofloxacin Generic | 25 | 27 | 18 | $346 |
| Omeprazole Generic | 21 | 45 | Under 11 | $214 |
| Fluticasone Propionate Generic | 19 | 21 | Under 11 | $228 |
| Doxycycline Hyclate Generic | 17 | 17 | 14 | $158 |
| Breo Ellipta Fluticasone/Vilanterol | 14 | 18 | Under 11 | $7,248 |
| Prednisone Generic | 11 | 14 | Under 11 | $152 |
Brand drugs: 175 claims; generic drugs: 467 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy R Aksamit $0 (- in general payments such as food, travel and fees) from 3 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.